Regulatory Impact of Selected U.S. FDA Postmarketing Safety Registries Conducted for Drugs Used to Treat Inflammatory or Autoimmune Conditions

美国FDA针对治疗炎症或自身免疫性疾病药物开展的部分上市后安全性注册研究的监管影响